MECP2 and atypical Rett syndrome: Mutations in MECP2, which consequently lead to the impairment of MeCP2 activity in the central nervous system (CNS), are the prime cause of Rett syndrome (RTT), a severe neurodevelopmental disease affecting 1 in 10,000 female live births (Amir et al., 1999).